FDA approves oral GLP-1 weight-loss pill
The US Food and Drug Administration (FDA) has approved weight-loss drug Wegovy as the first once-daily oral GLP-1 weight-loss pill. The FDA approved the first oral GLP‑1 medication for chronic
The US Food and Drug Administration (FDA) has approved weight-loss drug Wegovy as the first once-daily oral GLP-1 weight-loss pill. The FDA approved the first oral GLP‑1 medication for chronic
The US Food and Drug Administration (FDA) has issued warnings to patients and healthcare providers after serious complications were reported from radiofrequency (RF) microneedling devices. According to the FDA, reported
The US Food and Drug Administration (FDA) has issued a new warning about finasteride, a drug commonly prescribed for androgenic alopecia. The agency highlighted potential risks of serious, long-term side
The US Food and Drug Administration (FDA) has approved Allergan Aesthetics’ Botox Cosmetic (onabotulinumtoxinA) to treat moderate to severe vertical platysma bands. The approval was supported by phase III clinical
Belotero Balance hyaluronic acid (HA) dermal filler from pharmaceutical company Merz Aesthetics has received US Food and Drug Administration (FDA) approval for under-eye treatments.
Medical device company Sofwave has received US Food and Drug Administration (FDA) clearance for a cellulite treatment to add to its SUPERB (synchronous ultrasound parallel beam) technology.
The SUPERB technology by aesthetic medical device company Sofwave Medical has received clearance by the US Food and Drug Administration (FDA).
Laser manufacturer Cutera has launched the new truSculpt flex+
Aesthetic device Emerald Laser are hosting a webinar on addressing holiday weight.
The US Food and Drug Administration (FDA) has issued a safety communication regarding the use of needle-free injection devices for fillers.